Company Overview and News
Halvorsen's 13F portfolio value increased from $14.85B to $15.44B. The number of positions increased from 53 to 59. (1331-3)
Anthem Inc (ANTM - Free Report) is well poised for long-term growth on the back of its membership base that has strengthened due to strategic acquisitions, growing national accounts in the commercial segment and the Medicaid expansion in the government segment. Apart from this, Anthem’s revenues have also been driven by net investment income that started increasing since 2016 due to the interest rate hikes. (96-0)
Chicago, IL – November 17, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include TOTAL S.A. (TOT - Free Report) , Humana (HUM - Free Report) , Novo Nordisk (NVO - Free Report) , Target (TGT - Free Report) and Xcel (XEL - Free Report) . (68-0)
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including TOTAL S.A. (TOT), Humana (HUM) and Novo Nordisk (NVO). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. (20-0)
Humana Inc (NYSE:HUM) is a $34.9 billion in market value member of the Health Care Providers & Services GICS industry group where Portfolio Grader's current ranking for HUM puts it 17 among the 82 companies in this industry group, giving it a well above-average position. HUM is ranked in the top quartile of the sector with a ranking of 89 among the 782 companies in the sector and number 577 in the 5000 company Portfolio Grader company universe.
We introduce the history and little known facts about Medicaid including a 20-year mega-shift towards Medicaid away from private employer health insurance. (145-0)
Dan Loeb's 13F portfolio value increased 5.45% from $11.28B to $11.90B this quarter. The number of positions increased from 32 to 37. (1016-2)
Health insurer Anthem Inc has eased access to Sarepta Therapeutics' treatment for Duchenne muscular dystrophy, and on Thursday changed its reimbursement policy on its website to "medically necessary." (146-0)
NEW YORK (Reuters) - Health insurer Anthem Inc has eased access to Sarepta Therapeutics’ treatment for Duchenne muscular dystrophy, and on Thursday changed its reimbursement policy on its website to “medically necessary.” (146-0)
Humana Inc (NYSE:HUM) is a $37.1 billion in market value constituent of the Health Care Providers & Services GICS industry group where the stock's Portfolio Grader ranking places it 9 among the 82 companies in this industry group, putting in the top quartile. HUM is ranked in the top decile of the sector with a ranking of 51 among the 785 companies in the sector and number 372 in the 5000 company Portfolio Grader company universe.
Humana Inc.’s (HUM - Free Report) third-quarter 2017 operating earnings per share of $3.39 beat the Zacks Consensus Estimate by approximately 3.7%. The bottom line improved 6.6% year over year driven by lower share count. (75-0)
Humana Inc. (HUM - Free Report) is one of the largest health care plan providers in the United States. (18-0)
(Reuters) - U.S. health insurer Humana Inc (HUM.N) topped Wall Street expectations for third-quarter profit on Wednesday, benefiting largely from strength in its Medicare Advantage business that sells plans to the elderly and the disabled.
U.S. stock futures on Wednesday pointed to little change at the open, putting the Dow Jones Industrial Average on track for a pause after it edged up to another record close. (113-0)
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (91-0)
2017-10-28 - Wilton
2017-10-25 - Wilton
2017-10-10 - Wilton
2017-10-09 - Wilton
2017-08-25 - Wilton